Department Of Clinical Medicine 2
51. Potential of E-Learning Interventions and Artificial Intelligence–Assisted Contouring Skills in Radiotherapy: The ELAISA Study
52. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
53. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
54. Tetracyclines in the Modern Era: Global Consumption, Antimicrobial Resistance, Environmental Occurrence, and Degradation Techniques
55. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
56. Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke prevention
57. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
58. ChatGPT as a Clinical Decision Maker for Urolithiasis: Compliance with the Current European Association of Urology Guidelines
59. Potential of AI-Driven Chatbots in Urology: Revolutionizing Patient Care Through Artificial Intelligence
60. Metabolically healthy obesity: Misleading phrase or healthy phenotype?
61. Patient perspectives on vasectomy: findings from a TikTok® content analysis
62. Ureteroscopy for stone disease in the elderly (≥ 80 years): Outcomes of a multicentre study from YAU and EAU endourology groups
63. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry
64. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
65. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
66. Global burden of metabolic diseases, 1990–2021
67. Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
68. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
1 2 2